DOI:
10.1039/C6RA14018A
(Paper)
RSC Adv., 2016,
6, 73547-73550
Ag-catalyzed diastereoselective [6 + 3] cycloaddition of tropone with homoserine lactone-derived azomethine ylides: synthesis of tricyclic spiropiperidines†
Received
30th May 2016
, Accepted 26th July 2016
First published on 27th July 2016
Abstract
Ag-catalyzed [6 + 3] cycloaddition of tropone with homoserine lactone derived azomethine ylides has been developed. The reaction works efficiently under mild conditions to give tricyclic spiropiperidines in moderate to excellent yields with excellent diastereoselectivities.
The 1,3-dipolar cycloaddition reaction provides a reliable tool for synthesis of diverse heterocyclic compounds from simple starting materials.1 In the past three decades, lots of 1,3-dipolar cycloaddition reactions of a wide range of 1,3-dipoles such as azomethine ylides, azomethine imines, nitrones, carbonyl ylides and azides etc. have successfully been developed. Among these cycloadditions, the 1,3-diploar cycloaddition reactions with the use of azomethine ylide as one of the reaction partners have become an active research area,2 since Zhang3 and Jørgensen4 reported the first example of the catalytic asymmetric 1,3-dipolar [3 + 2] cycloaddition of azomethine ylides derived from iminoesters with activated alkenes. A variety of cycloaddition reactions involving azomethine ylides such as [3 + 2],2,5 [3 + 3]6 and [6 + 3]7 cycloadditions have been reported. Especially, the catalytic asymmetric 1,3-dipolar [3 + 2] cycloaddition of azomethine ylides with electron-deficient alkenes is the most studied reaction in these reactions and has emerged as an extremely useful tool for the enantioselective preparation of structurally diverse pyrrolidines.2,5 Besides well-established [3 + 2] cycloaddition reactions,2,5 other types of cycloaddition reactions of azomethine ylides have also attracted increasing attention in recent five years.6,7 Particularly, since the higher-order cycloaddition provides a rapid and facile excess to medium-sized carbo- and heterocycles from a wide range of simpler precursors, the research on higher-order cycloaddition of azomethine ylides is very significant. However, in contrast to the substantial amount of work on [3 + 2] cycloaddition reactions of azomethine ylides, the research on these higher-order cycloaddition reactions is not very fruitful and only very limited successful examples have been disclosed. In 2003, [6 + 3] cycloaddition of azomethine ylides with fulvenes was first achieved to give piperidine derivatives with high stereoselectivity.7a Nearly ten years later, through using chiral copper catalyst, catalytic asymmetric [6 + 3] cycloaddition of azomethine ylides with fulvenes was also developed, providing chiral piperidine derivatives with four stereocenters in high yields with high regio- and enantioselectivities.7b–d In 2014, metal-catalyzed [6 + 3] cycloaddition of azomethine ylides with tropone was accomplished to afford piperidine-fused bicyclic heterocycles in moderate to excellent yields with excellent enantioselectivities and moderate to excellent diastereoselectivies.7e,f Most recently, metal-catalyzed asymmetric [6 + 3] cycloaddition of azomethine ylides with acyl cycloheptatrienes was disclosed to produce piperidine derivatives in moderate to high yields with good to excellent diastereo- and enantioselectivies.7g,h On the basis of our previous work on [6 + 3] cycloaddition of azomethine ylides with tropone,7e we hope to continue to expand the scope of azomethine ylides to homoserine lactone-derived azomethine ylides, which provide a good scaffold for synthesis of spirocyclic heterocyclic compounds. The homoserine lactone-derived azomethine ylides could be conveniently prepared from homoserine lactone and aldehydes, and have been used in couples of cycloaddition reactions for synthesis of spirocyclic heterocyclic compounds.6b,8 As the other reaction partner, tropone is commercially available and a very useful substrate for higher-order cycloaddition reaction. With the use of tropone as the component, a range of cycloaddition reactions including [6 + 3],9 [6 + 4],10 [8 + 2],11 or [8 + 3]12 cycloadditions had been achieved for synthesis of bioactive molecules and natural products.13 As our continuous efforts on 1,3-dipoles-based cycloaddition reactions,14 we herein present Ag-catalyzed [6 + 3] cycloaddition of tropone with homoserine lactone derived azomethine ylides to synthesize biologically important tricyclic spiropiperidine derivatives (Scheme 1).
 |
| Scheme 1 Ag-catalyzed [6 + 3] cycloaddition of tropone with homoserine lactone derived azomethine ylides. | |
Our studies began with the identification of the optimized reaction conditions using tropone 1a and homoserine lactone 2a as model substrate (Table 1). In our previous work,7e we have observed that Ag(I)/Ph3P catalytic system was very efficient for [6 + 3] cycloaddition of tropone with azomethine ylides. On the basis of these observations, we first screened a series of Ag(I) salts in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) with the use of methanol as the solvent at room temperature (entries 1–5). As showed in the Table 1, several commercially available Ag salts such as AgBF4, AgSO3CF3, AgSO3CH3 and AgCO2CF3 could promote the reaction, but only produced the tricyclic spiropiperidine derivative 3a as major diastereomer in moderate yields with excellent enantioselectivity (>20
:
1 dr). In contrast, AgOAc displayed very excellent catalytic activity, leading to the cycloadduct 3a in 92% yield (entry 5). Further attempts to improve the yield through variation of amount of DBU were not successful. Decreasing the amount of DBU to 10 mol% led to a dramatic drop of yield to 30% (entry 6). But increasing the amount of DBU to 30 mol% had no influence on the yield (entry 7). In order to further increase the yield, several Lewis bases such as triethylamine (Et3N), 1,4-diazabicyclo[2.2.2]octane (DABCO) and 4-dimethylaminopyridine (DMAP) were also investigated. Unfortunately, all these bases resulted in lower yields than DBU did (entries 8–10). With the use of AgOAc/PPh3 (10 mol%) as the catalyst and DBU (20 mol%) as the base, we next screened a series of solvents (entries 11–13). The results showed that in dichloromethane, THF or CH3CN, only poor to moderate yields were obtained. Finally, we tried increasing the reaction temperature to further improve the reaction yield, but a slight lower yield was observed, in comparison with the yield at room temperature (entry 14 vs. 5). The relative configuration of the cycloadduct 3a was determined by X-ray crystallographic analysis (Fig. 1).15
Table 1 Screening of the reaction conditionsa
 |
| Fig. 1 The X-ray crystallographic structure of the product 3a. | |
Under the optimized reaction conditions, a range of homoserine lactone derived azomethine ylides were investigated. As shown in Table 2, with the use of AgOAc/PPh3 as the catalyst and in the presence of DBU, various azomethine ylides prepared from homoserine lactone and aromatic aldehydes bearing both electron-donating and electron-withdrawing substituents underwent [6 + 3] cycloaddition with tropone at room temperature to afford tricyclic spiropiperidine heterocyclic compounds (3b–3k) in moderate to good yields with excellent diastereoselectivities (>20
:
1 dr). The position of substituent on the benzene ring in the azomethine ylides seemed to have no remarkable influence on the yield and diastereoselectivity. Particularly, the azomethine ylides prepared from 2-CH3, 4-OCH3 and 2-F substituted benzaldehydes were not very reactive and carried out the reaction to provide the corresponding tricyclic spiropiperidine derivative in moderate yields. Notably, 1-naphthyl substituted-azomethine ylide underwent [6 + 3] cycloaddition under the standard reaction conditions to give the cycloadduct 3k in 67% yield with excellent diastereoselectivity.
Table 2 Substrate scope of Ag-catalyzed [6 + 3] cycloaddition of tropone with azomethine ylidesa,b,c
Experimental
Unless otherwise stated, all reagents were purchased from commercial suppliers and used without further purification. Organic solutions were concentrated under reduced pressure using a rotary evaporator or oil pump. Reactions were monitored through thin-layer chromatography (TLC). Chromatograms were visualized by fluorescence quenching under UV light at 254 nm. Flash column chromatography was performed using Qingdao Haiyang flash silica gel (200–300 mesh). Infrared spectra were recorded using a Bruker Optics TENSOR 27 instrument. 1H and 13C NMR spectra were recorded using a Bruker-300 spectrometer. Accurate mass measurements were performed using an Agilent instrument with the ESI-MS technique.
General procedure for the [6 + 3] cycloaddition between tropone and azomethine ylides by AgOAc/PPh3: under nitrogen atmosphere, AgOAc (5.0 mg, 0.03 mmol) and triphenylphosphine (15.8 mg, 0.06 mmol) were dissolved in 1 mL of methanol. The resulting mixture was stirred at room temperature for about 1 hour, followed by addition of tropone 1 (0.3 mmol, 30 μL), α-iminoesters 2 (0.45 mmol), DBU (9.1 mg, 0.06 mmol) and methanol (2 mL). Upon completion of the reaction as monitored by TLC (about 10 hours), the mixture was concentrated in vacuo. The residue was purified through flash column chromatography (EtOAc/petroleum ether) to afford the corresponding product.
Conclusions
In conclusion, we have successfully accomplished a diastereoselective [6 + 3] cycloaddition of tropone with homoserine lactone derived azomethine ylides with the use of AgOAc/PPh3 as the catalyst in the presence of DBU. The reaction worked well under mild conditions to produce a range of tricyclic spiropiperidine in moderate to excellent yields with excellent diastereoselectivities.
Acknowledgements
We are greatly thankful for the financial support from the National Natural Science Foundation of China (No. 21372256 and 21572264), the National S&T Pillar Program of China (2015BAK45B01) and Special Research Fund for the Doctoral Program of Higher Education (No. 20120008110038).
Notes and references
- For selected reviews, see:
(a) K. V. Gothelf and K. A. Jørgensen, Chem. Rev., 1998, 98, 863 CrossRef CAS PubMed;
(b) K. V. Gothelf, in Cycloaddition Reactions in Organic Synthesis, ed. S. Kobayashi and K. A. Jorgensen, Wiley-VCH, Weinheim, 2002, pp. 211–247 Search PubMed;
(c) Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry—Toward Heterocycles and Natural Products, ed. A. Padwa and W. H. Pearson, John Wiley and Sons, Hoboken, NJ, 2003 Search PubMed;
(d) T. Hashimoto and K. Maruoka, in Handbook of Cyclization Reactions, ed. S. Ma, Wiley-VCH, Weinheim, Germany, 2009, ch. 3, pp. 87–168 Search PubMed.
- For selected reviews, see:
(a) C. Nájera and J. M. Sansano, Angew. Chem., Int. Ed., 2005, 44, 6272 CrossRef PubMed;
(b) J. Adrio and J. C. Carretero, Chem. Commun., 2011, 47, 6784 RSC;
(c) J. Adrio and J. C. Carretero, Chem. Commun., 2014, 50, 12434 RSC;
(d) R. Narayan, M. Potowski, Z.-J. Jia, A. P. Antonchick and H. Waldmann, Acc. Chem. Res., 2014, 47, 1296 CrossRef CAS PubMed;
(e) H. Takuya and M. Keiji, Chem. Rev., 2015, 115, 5366 CrossRef PubMed;
(f) M. S. Singh, S. Chowdhury and S. Koley, Tetrahedron, 2016, 72, 1603 CrossRef CAS.
- J. M. Longmire, B. Wang and X. Zhang, J. Am. Chem. Soc., 2002, 124, 13400 CrossRef CAS PubMed.
- A. S. Gothelf, K. V. Gothelf, R. G. Hazell and K. A. Jørgensen, Angew. Chem., Int. Ed., 2002, 41, 4236 CrossRef CAS.
- For selected recent examples on [3 + 2] cycloadditions:
(a) E. E. Maroto, S. Filippone, M. Suarez, R. Martinez-Alvarez, A. de Cozar, F. P. Cossio and N. Martin, J. Am. Chem. Soc., 2014, 136, 705 CrossRef CAS PubMed;
(b) J. D. Li, H. B. Zhao, X. J. Jiang, X. C. Wang, H. M. Hu, L. Yu and Y. D. Zhang, Angew. Chem., Int. Ed., 2015, 54, 6306 CrossRef CAS PubMed;
(c) S. R. Vidadala, C. Golz, C. Strohmann, C.-G. Daniliuc and H. Waldmann, Angew. Chem., Int. Ed., 2015, 54, 651 CAS.
-
(a) H. Guo, H. Liu, F.-L. Zhu, R. Na, H. Jiang, Y. Wu, L. Zhang, Z. Li, H. Yu, B. Wang, Y. Xiao, X.-P. Hu and M. Wang, Angew. Chem., Int. Ed., 2013, 52, 12641 CrossRef CAS PubMed;
(b) M.-C. Tong, X. Chen, H.-Y. Tao and C.-J. Wang, Angew. Chem., Int. Ed., 2013, 52, 12377 CrossRef CAS PubMed;
(c) J. Huang, S. Luo and L. Gong, Acta Chim. Sin., 2013, 71, 879 CrossRef CAS;
(d) F. Shi, R.-Y. Zhu, W. Dai, C.-S. Wang and S.-J. Tu, Chem.–Eur. J., 2014, 20, 2597 CrossRef CAS PubMed;
(e) W. Dai, H. Lu, X. Li, F. Shi and S.-J. Tu, Chem.–Eur. J., 2014, 20, 11382 CrossRef CAS PubMed;
(f) C.-S. Wang, R.-Y. Zhu, Y.-C. Zhang and F. Shi, Chem. Commun., 2015, 51, 11798 RSC;
(g) Y. Wu, G. Qiao, H. Liu, L. Zhang, Z. Sun, Y. Xiao and H. Guo, RSC Adv., 2015, 5, 84290 RSC;
(h) C. Yuan, H. Liu, Z. Gao, L. Zhou, Y. Feng, Y. Xiao and H. Guo, Org. Lett., 2015, 17, 26 CrossRef CAS PubMed.
-
(a) B.-C. Hong, A. K. Gupta, M.-F. Wu, J.-H. Liao and G.-H. Lee, Org. Lett., 2003, 5, 1689 CrossRef CAS PubMed;
(b) M. Potowski, J. O. Bauer, C. Strohmann, A. P. Antonchick and H. Waldmann, Angew. Chem., Int. Ed., 2012, 51, 9512 CrossRef CAS PubMed;
(c) M. Potowski, A. P. Antonchick and H. Waldmann, Chem. Commun., 2013, 49, 7800 RSC;
(d) Z.-L. He, H.-L. Teng and C.-J. Wang, Angew. Chem., Int. Ed., 2013, 52, 2934 CrossRef CAS PubMed;
(e) H. Liu, Y. Wu, Y. Zhao, Z. Li, L. Zhang, W. Yang, H. Jiang, C. Jing, H. Yu, B. Wang, Y. Xiao and H. Guo, J. Am. Chem. Soc., 2014, 136, 2625 CrossRef CAS PubMed;
(f) H.-L. Teng, L. Yao and C.-J. Wang, J. Am. Chem. Soc., 2014, 136, 4075 CrossRef CAS PubMed;
(g) Q. H. Li, L. Wei and C. J. Wang, J. Am. Chem. Soc., 2014, 136, 8685 CrossRef CAS PubMed;
(h) Z.-L. He, F. K. Sheong, Q.-H. Li, Z. Lin and C.-J. Wang, Org. Lett., 2015, 17, 1365 CrossRef CAS PubMed.
-
(a) R. Grigg and M. A. B. Sarker, Tetrahedron, 2006, 62, 10332 CrossRef CAS;
(b) R. Grigg, C. Kilner, M. A. B. Sarker, C. Orgaz de la Cierva and H. A. Dondas, Tetrahedron, 2008, 64, 8974 CrossRef CAS;
(c) T.-L. Liu, Z.-L. He, H.-Y. Tao and C.-J. Wang, Chem.–Eur. J., 2012, 18, 8042 CrossRef CAS PubMed;
(d) Q.-H. Li, T.-L. Liu, L. Wei, X. Zhou, H.-Y. Tao and C.-J. Wang, Chem. Commun., 2013, 49, 9642 RSC;
(e) K. Liu, H.-L. Teng, L. Yao, H.-Y. Tao and C.-J. Wang, Org. Lett., 2013, 15, 2250 CrossRef CAS PubMed;
(f) L. Wang, X.-M. Shi, W.-P. Dong, L.-P. Zhu and R. Wang, Chem. Commun., 2013, 49, 3458 RSC;
(g) Q.-H. Li, T.-L. Liu, L. Wei, X. Zhou, H.-Y. Tao and C.-J. Wang, Chem. Commun., 2013, 49, 9642 RSC;
(h) X. Fang, X.-Q. Dong and C.-J. Wang, Tetrahedron Lett., 2014, 55, 5660 CrossRef CAS;
(i) T.-L. Liu, Q.-H. Li, Z.-L. He, J.-W. Zhang and C.-J. Wang, Chin. J. Catal., 2015, 36, 68 CrossRef CAS;
(j) H.-C. Liu, H.-Y. Tao, H.-J. Cong and C.-J. Wang, J. Org. Chem., 2016, 81, 3752 CrossRef CAS PubMed.
-
(a) B. M. Trost and P. R. Seoane, J. Am. Chem. Soc., 1987, 109, 615 CrossRef CAS;
(b) Y. Du, J. Feng and X. Lu, Org. Lett., 2005, 7, 1987 CrossRef CAS PubMed;
(c) B. M. Trost, P. J. McDougall, O. Hartmann and P. T. Wathen, J. Am. Chem. Soc., 2008, 130, 14960 CrossRef CAS PubMed;
(d) B. M. Trost and P. J. McDougall, Org. Lett., 2009, 11, 3782 CrossRef CAS PubMed.
-
(a) L. Isakovic, J. A. Ashenhurst and J. L. Gleason, Org. Lett., 2001, 3, 4189 CrossRef CAS PubMed;
(b) J. H. Rigby and M. Fleming, Tetrahedron Lett., 2002, 43, 8643 CrossRef CAS;
(c) J. H. Rigby and G. Chouraqui, Synlett, 2005, 2501 CrossRef CAS;
(d) J. A. Ashenhurst, L. Isakovic and J. L. Gleason, Tetrahedron, 2010, 66, 368 CrossRef CAS.
-
(a) V. Nair and K. G. Abhilash, Top. Heterocycl. Chem., 2008, 13, 173 CAS;
(b) K. Kumar, A. Kapur and M. P. S. Ishar, Org. Lett., 2000, 2, 787 CrossRef CAS PubMed;
(c) J. Okamoto, S. Yamabe, T. Minato, T. Hasegawa and T. Machiguchi, Helv. Chim. Acta, 2005, 88, 1519 CrossRef CAS;
(d) M. L. Lage, I. Fernández, M. A. Sierra and M. R. Torres, Org. Lett., 2011, 13, 2892 CrossRef CAS PubMed;
(e) A. R. Rivero, I. Fernández and M. A. Sierra, J. Org. Chem., 2012, 77, 6648 CrossRef CAS PubMed;
(f) M. Xie, X. Liu, X. Wu, Y. Cai, L. Lin and X. Feng, Angew. Chem., Int. Ed., 2013, 52, 5604 CrossRef CAS PubMed.
-
(a) V. Nair, M. Poonoth, S. Vellalath, E. Suresh and R. Thirumalai, J. Org. Chem., 2006, 71, 8964 CrossRef CAS PubMed;
(b) C. Chen, X. Shao, K. Yao, W. Shangguan, T. Kawaguchi and K. Shimazu, Langmuir, 2011, 27, 11958 CrossRef CAS PubMed;
(c) R. Tejero, A. Ponce, J. Adrio and J. C. Carretero, Chem. Commun., 2013, 49, 10406 RSC;
(d) A. R. Rivero, I. Fernández and M. Á. Sierra, Org. Lett., 2013, 15, 4928 CrossRef CAS PubMed.
-
(a) J. H. Rigby, Stud. Nat. Prod. Chem., 1988, 1, 545 CAS;
(b) G. Fischer, Adv. Heterocycl. Chem., 1996, 66, 285 CrossRef CAS;
(c) J. Zhao, Curr. Med. Chem., 2007, 14, 2597 CrossRef CAS PubMed;
(d) R. Bentley, Nat. Prod. Rep., 2008, 25, 118 RSC.
-
(a) R. Na, C. Jing, Q. Xu, H. Jiang, X. Wu, J. Shi, J. Zhong, M. Wang, D. Benitez, E. Tkatchouk, W. A. Goddard III, H. Guo and O. Kwon, J. Am. Chem. Soc., 2011, 133, 13337 CrossRef CAS PubMed;
(b) C. Jing, R. Na, B. Wang, H. Liu, L. Zhang, J. Liu, M. Wang, J. Zhong, O. Kwon and H. Guo, Adv. Synth. Catal., 2012, 354, 1023 CrossRef CAS PubMed;
(c) H. Yu, L. Zhang, Z. Yang, Z. Li, Y. Zhao, Y. Xiao and H. Guo, J. Org. Chem., 2013, 78, 8427 CrossRef CAS PubMed;
(d) Z. Li, H. Yu, H. Liu, L. Zhang, H. Jiang, B. Wang and H. Guo, Chem.–Eur. J., 2014, 20, 1731 CrossRef CAS PubMed;
(e) Z. Li, H. Yu, Y. Feng, Z. Hou, L. Zhang, W. Yang, Y. Wu, Y. Xiao and H. Guo, RSC Adv., 2015, 5, 34481 RSC;
(f) L. Zhang, H. L. Liu, G. Qiao, Z. Hou, Y. Liu, Y. Xiao and H. Guo, J. Am. Chem. Soc., 2015, 137, 4316 CrossRef CAS PubMed;
(g) H. Liu, C. Yuan, Y. Wu, Y. Xiao and H. Guo, Org. Lett., 2015, 17, 4220 CrossRef CAS PubMed;
(h) H. Liu, Y. Liu, C. Yuan, G.-P. Wang, S.-F. Zhu, Y. Wu, B. Wang, Z. Sun, Y. Xiao, Q.-L. Zhou and H. Guo, Org. Lett., 2016, 18, 1302 CrossRef CAS PubMed;
(i) Z. Li, H. Yu, Y. Liu, L. Zhou, Z. Sun and H. Guo, Adv. Synth. Catal., 2016, 358, 1880 CrossRef CAS.
- ESI†.
Footnote |
† Electronic supplementary information (ESI) available. CCDC 1473250. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra14018a |
|
This journal is © The Royal Society of Chemistry 2016 |
Click here to see how this site uses Cookies. View our privacy policy here.